等待開盤 07-23 09:30:00 美东时间
-1.690
-1.93%
Inhibrx Biosciences Inc ( ($INBX) ) just unveiled an announcement. On July 15, ...
07-17 17:17
The US FDA has accepted for review Inhibrx Biosciences' (INBX) BLA for ozekibart to treat unresectable or metastatic conventional chondrosarcoma. The application has an action date of April 14, 2027. ...
06-15 22:34
No filing review issues identified by FDA with PDUFA goal date set for April 14, 2027 If Approved, Ozekibart Would Be the First and Only FDA-Approved Treatment for Unresectable or Metastatic Conventional Chondrosarcoma SAN DIEGO, June 15, 2026 /PRNewswire/ -- Inhibrx Biosciences, Inc. (NASDAQ:INBX) ...
06-15 21:19
2026年5月27日,来自江苏苏州的科望医药集团Elpiscience Biopharmaceuticals, Inc.(简称科望医药)在港交所递交...
06-07 21:27
Inhibrx Biosciences press release (INBX): Q1 GAAP EPS of -$2.15. Cash and Cash Equivalents. As of March 31, 2026, the Company had cash and cash equivalents of $161.7 million, as compared to $124.2 mil...
05-15 04:46
Inhibrx Biosciences (NASDAQ:INBX) reported quarterly losses of $(2.15) per share which missed the analyst consensus estimate of $(1.79) by 20.11 percent. This is a 23.21 percent increase over losses of $(2.80) per share
05-15 04:38
Fundrise Innovation Fund, LLC涨16.13%;奇景光电涨11.30%;Inhibrx Biosciences, Inc.涨11.28%
05-11 13:01